TipRanks
Go Ultimate55% OFF

Compare MeVis Medical Solutions (M3V) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M3VMeVis Medical SolutionsEUR 19.90EUR 36.40M26.18-21.03%―Unlock the DE:M3V analyst price target with TipRanks PremiumDE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 28.15EUR 1.48B43.4214.34%―Unlock the DE:COP analyst price target with TipRanks PremiumDE:M3V vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:DRW8Draegerwerk AG & Co. KGaAEUR 78.80EUR 1.67B11.7931.77%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumDE:M3V vs DE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 14.00EUR 837.87M17.50-14.69%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumDE:M3V vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 25.55EUR 303.90M-638.7514.83%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumDE:M3V vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 44.85EUR 48.37B22.65-8.93%Moderate BuyUnlock the DE:SHL analyst price target with TipRanks PremiumDE:M3V vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-40%-20%0%20%40%60%80%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M3VMeVis Medical Solutions19.90-5.10-20.40%
DE:COPCompuGroup Medical28.154.5719.40%
DE:DRW8Draegerwerk AG & Co. KGaA78.8021.7938.23%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik14.00-1.66-10.63%
DE:SBSSTRATEC Biomedical25.555.5928.01%
DE:SHLSiemens Healthineers AG44.851.603.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts